4//SEC Filing
Tulip Thomas H. 4
Accession 0001225208-12-019632
CIK 0000810509other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 1:42 PM ET
Size
5.5 KB
Accession
0001225208-12-019632
Insider Transaction Report
Form 4
Tulip Thomas H.
Other
Transactions
- Purchase
Common Stock
2012-09-14$2.70/sh+15,000$40,500→ 27,500 total
Holdings
- 940(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $2.66 to $2.72. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.
- [F2]Total includes shares acquired under the Neoprobe Corporation 401(k) Plan.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001528192
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 1:42 PM ET
- Size
- 5.5 KB